Tourmaline Bio, Inc. (TRML) has 9 open-market insider trades by 5 insiders since 2023. The most active filer is Sandeep Chidambar Kulkarni, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mark McDade | Dir | — | 1 | $3.3M | 2025-10-28 |
| Sandeep Chidambar Kulkarni | CEO | — | 4 | $349K | 2025-10-28 |
| Caley Castelein | Dir | — | 1 | $281K | 2025-10-28 |
| Parvinder Thiara | Dir | — | 2 | $95K | 2025-10-28 |
| Aaron Kantoff | Dir | — | 1 | $89K | 2025-10-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sandeep Chidambar Kulkarni | CEO | Buy | $26K | 2024-08-21 |
| Sandeep Chidambar Kulkarni | CEO | Buy | $144K | 2024-08-16 |
| Mark McDade | Director | Buy | $3.3M | 2024-01-29 |
| Parvinder Thiara | Director | Buy | $17K | 2023-11-17 |
| Sandeep Chidambar Kulkarni | CEO | Buy | $68K | 2023-11-17 |
| Caley Castelein | Director | Buy | $281K | 2023-10-25 |
Companies that share insiders with TRML, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sandeep Chidambar Kulkarni | CEO | Buy | $111K | 2023-10-24 |
| Aaron Kantoff | Director | Buy | $89K | 2023-10-24 |
| Parvinder Thiara | Director | Buy | $78K | 2023-10-24 |